Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-19.05 Insider Own4.14% Shs Outstand0.99M Perf Week-77.97%
Market Cap1.75M Forward P/E0.10 EPS next Y17.00 Insider Trans292.78% Shs Float0.95M Perf Month-68.48%
Income-4.51M PEG- EPS next Q-8.00 Inst Own11.83% Short Float0.74% Perf Quarter-92.44%
Sales24.09M P/S0.07 EPS this Y115.79% Inst Trans- Short Ratio0.02 Perf Half Y-94.34%
Book/sh75.67 P/B0.02 EPS next Y466.67% ROA-15.84% Short Interest0.01M Perf Year-97.48%
Cash/sh16.45 P/C0.11 EPS next 5Y- ROE-21.04% 52W Range3.10 - 140.00 Perf YTD-93.50%
Dividend Est.- P/FCF- EPS past 5Y73.50% ROI-20.72% 52W High-98.74% Beta-0.89
Dividend TTM- Quick Ratio3.45 Sales past 5Y542.96% Gross Margin33.99% 52W Low-43.06% ATR (14)1.95
Dividend Ex-Date- Current Ratio4.48 EPS Y/Y TTM86.26% Oper. Margin-18.66% RSI (14)31.37 Volatility40.05% 24.59%
Employees44 Debt/Eq0.03 Sales Y/Y TTM454.42% Profit Margin-18.70% Recom1.00 Target Price300.00
Option/ShortNo / Yes LT Debt/Eq0.03 EPS Q/Q94.97% Payout- Rel Volume32.16 Prev Close3.32
Sales Surprise25.90% EPS Surprise-66.67% Sales Q/Q94.94% EarningsMar 28 BMO Avg Volume358.00K Price1.76
SMA20-76.47% SMA50-77.33% SMA200-93.66% Trades Volume11,514,865 Change-46.84%
Apr-19-24 08:00AM
Apr-12-24 09:00AM
Apr-08-24 01:53PM
Apr-01-24 08:00AM
Mar-04-24 09:18AM
09:15AM Loading…
Feb-15-24 09:15AM
Feb-13-24 09:00AM
Dec-04-23 08:30AM
Nov-13-23 08:30AM
Sep-21-23 09:05PM
Aug-11-23 08:30AM
May-16-23 02:15PM
May-12-23 08:00AM
May-11-23 09:00AM
08:00AM Loading…
Apr-05-23 08:00AM
Feb-28-23 07:30AM
Feb-10-23 07:35AM
Jan-19-23 07:30AM
Dec-27-22 08:00AM
Dec-20-22 08:00AM
Nov-23-22 11:20AM
Nov-16-22 10:12AM
Nov-13-22 07:52AM
Nov-07-22 09:28AM
Oct-20-22 08:00AM
Aug-08-22 08:15AM
Aug-04-22 08:00AM
08:10AM Loading…
Jul-28-22 08:10AM
Jun-27-22 05:30AM
Apr-28-22 04:50PM
Apr-26-22 08:13AM
Apr-25-22 08:00AM
Apr-19-22 06:45PM
Apr-08-22 09:44AM
Apr-05-22 03:45PM
Mar-15-22 09:45AM
Mar-14-22 06:12PM
Mar-10-22 09:17AM
Feb-25-22 08:00AM
Feb-17-22 10:40AM
Feb-15-22 09:00AM
Dec-22-21 08:52AM
Nov-03-21 12:35PM
Oct-06-21 08:00AM
Aug-12-21 09:00AM
Jul-27-21 09:00AM
Jul-20-21 09:00AM
Jul-08-21 09:00AM
Sunshine Biopharma, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of oncology and antiviral drugs. It is also involved in the development and commercialization of science-based nutritional supplements. The firm's product includes treatment for Coronavirus infections and anticancer drugs. The company was founded on August 31, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Slilaty Steve N.Chief Executive OfficerMar 04 '24Buy0.10100,00010,000130,000Mar 05 04:05 PM
Slilaty Steve N.Chief Executive OfficerFeb 08 '24Buy0.1020,0002,00030,000Feb 12 04:05 PM